IP Library Granted Patent US 11,103,224
Granted Patent B2
US 11,103,224 · App. 16/055,736 · Granted Aug 31, 2021

Apparatus and methods for sealing a vascular puncture

Inventors: Andy H. Uchida (Los Altos, CA); Anthony P. Spizuoco (San Francisco, CA); Kevin To (San Jose, CA); Florencia Lim (Union City, CA); Scott R. Sershen (Foster City, CA)
Assignee: ACCESS CLOSURE, INC.
A61B17/0057A61L24/02C08L71/02A61B90/90A61B2017/0065A61B2017/00495A61B2017/00526A61B2017/00561A61B2017/00871A61B2017/00884A61B2017/00889A61B2017/00893A61B2017/00898A61B2017/00951A61B2017/22067A61B2017/22069
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,103,224
App. No.
16/055,736
Granted
Aug 31, 2021
Kind
B2
Abstract

A sealant is provided for sealing a puncture through tissue that includes an elongate first section including a proximal end, a distal end, and a cross-section sized for delivery into a puncture through tissue, and a second section fused to and extending from the distal end of the first section. The first section may be formed from a freeze-dried hydrogel that expands when exposed to physiological fluid within a puncture. The second section may be formed from a solid mass of non-freeze-dried, non-crosslinked hydrogel precursors, the precursors remaining in an unreactive state until exposed to an aqueous physiological, whereupon the precursors undergo in-situ crosslinking with one another to provide an adhesive layer bonded to the first section. Apparatus and methods for delivering the sealant into a puncture through tissue are also provided.

Claims (33)

1. A sealant for sealing a puncture through tissue, comprising:

a freeze-dried hydrogel comprising crosslinked polyethylene glycol (PEG), the freeze-dried hydrogel having pores; and

a solid mass of non-freeze-dried, non-crosslinked hydrogel precursors, wherein the solid mass of hydrogel precursors is substantially distal to the freeze-dried hydrogel;

wherein the pores in a distal end of the freeze-dried hydrogel contain non-freeze-dried, non-crosslinked hydrogel precursors.

2. The sealant of claim 1 , wherein the solid mass of hydrogel precursors further comprises a pH adjusting agent.

3. The sealant of claim 1 , wherein the freeze-dried hydrogel has a length between a proximal end and the distal end thereof and the solid mass of hydrogel precursors has a length between a proximal end and the distal end thereof;

wherein the length of the freeze-dried hydrogel is between about one and twenty millimeters (1-20 mm), and the length of the solid mass of hydrogel precursors is substantially shorter than the length of the freeze-dried hydrogel.

4. The sealant of claim 1 , wherein the solid mass of hydrogel precursors comprises a sintered mass of precursor powders.

5. The sealant of claim 1 , wherein the solid mass of hydrogel precursors includes one or more reinforcement elements.

6. The sealant of claim 1 , wherein the freeze-dried hydrogel comprises a sheet rolled into a tubular shape.

7. The sealant of claim 1 , wherein the sealant comprises a lumen extending from a proximal end of the freeze-dried hydrogel to a distal end of the solid mass of hydrogel precursors.

8. A sealant for sealing a puncture through tissue, comprising:

a freeze-dried hydrogel comprising crosslinked polyethylene glycol (PEG), the freeze-dried hydrogel having pores;

a solid mass of non-freeze-dried, non-crosslinked hydrogel precursors, wherein the solid mass of hydrogel precursors is substantially distal to the freeze-dried hydrogel; and

a transition zone in a distal end of the freeze-dried hydrogel, wherein the pores of the freeze-dried hydrogel at the transition zone contain non-freeze-dried, non-crosslinked hydrogel precursors.

9. The sealant of claim 8 , wherein the solid mass of hydrogel precursors further comprises a pH adjusting agent.

10. The sealant of claim 8 , wherein the freeze-dried hydrogel has a length between a proximal end and the distal end thereof and the solid mass of hydrogel precursors has a length between a proximal end and the distal end thereof;

wherein the length of the freeze-dried hydrogel is between about one and twenty millimeters (1-20 mm), and the length of the solid mass of hydrogel precursors is substantially shorter than the length of the freeze-dried hydrogel.

11. The sealant of claim 8 , wherein the solid mass of hydrogel precursors comprises a sintered mass of precursor powders.

12. The sealant of claim 8 , wherein the solid mass of hydrogel precursors includes one or more reinforcement elements.

13. The sealant of claim 8 , wherein the freeze-dried hydrogel comprises a sheet rolled into a tubular shape.

14. The sealant of claim 8 , wherein the sealant comprises a lumen extending from a proximal end of the freeze-dried hydrogel to a distal end of the solid mass of hydrogel precursors.

15. A sealant for sealing a puncture through tissue, comprising:

a freeze-dried hydrogel comprising crosslinked polyethylene glycol (PEG), the freeze-dried hydrogel having pores; and

a solid mass of non-freeze-dried, non-crosslinked hydrogel precursors, wherein the solid mass of hydrogel precursors is substantially distal to the freeze-dried hydrogel;

wherein the solid mass of hydrogel precursors is formed by melting the hydrogel precursors, drawing the melted hydrogel precursors toward a distal end of the freeze-dried hydrogel such that some of the melted precursors permeate into the pores in the distal end of the freeze-dried hydrogel, and allowing the melted hydrogel precursors to solidify.

16. The sealant of claim 15 , wherein the solid mass of hydrogel precursors further comprises a pH adjusting agent.

17. The sealant of claim 15 , wherein the freeze-dried hydrogel has a length between a proximal end and the distal end thereof and the solid mass of hydrogel precursors has a length between a proximal end and the distal end thereof;

wherein the length of the freeze-dried hydrogel is between about one and twenty millimeters (1-20 mm), and the length of the solid mass of hydrogel precursors is substantially shorter than the length of the freeze-dried hydrogel.

18. The sealant of claim 15 , wherein the solid mass of hydrogel precursors comprises a sintered mass of precursor powders.

19. The sealant of claim 15 , wherein the solid mass of hydrogel precursors includes one or more reinforcement elements.

20. The sealant of claim 15 , wherein the freeze-dried hydrogel comprises a sheet rolled into a tubular shape.

21. The sealant of claim 15 , wherein the sealant comprises a lumen extending from a proximal end of the freeze-dried hydrogel to a distal end of the solid mass of hydrogel precursors.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Oct 9, 2025
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: ACCESS CLOSURE, INC.; CORDIS US CORP.
Reel/Frame 073060/0346 →
SECURITY INTEREST Recorded Oct 1, 2025
From: CORDIS US CORP.; ACCESS CLOSURE, LLC
To: HPS INVESTMENT PARTNERS, LLC
Reel/Frame 072973/0157 →
SECURITY INTEREST Recorded Aug 24, 2021
From: ACCESS CLOSURE, INC.; CORDIS US CORP.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 057292/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2018
From: UCHIDA, ANDY H; TO, KEVIN; LIM, FLORENCIA; SPIZUOCO, ANTHONY P; SERSHEN, SCOTT R
To: ACCESS CLOSURE, INC.
Reel/Frame 046954/0379 →
Continuity (3)
Division 13354278 · Jan 19, 2012
Provisional Application 61434412 · Jan 19, 2011
Related Publication 20190029659A1 · Jan 31, 2019
Cited By (1)
US 12,383,246